Nonsteroidal anti-inflammatory drug gastropathy: new avenues for safety

References

• Centers for Disease Control and PreventionArthritis-related statistics82010 Available from: http://www.cdc.gov/arthritis/data_statistics/arthritis_related_stats.htm. Accessed October 19, 2010.
   Google Scholar
• American College of Rheumatology Subcommittee on Osteoarthritis GuidelinesRecommendations for the medical management of osteoarthritis of the hip and knee: 2000 updateArthritis Rheum20004391905191511014340
   PubMed Web of Science ®Google Scholar
• HarirforooshSJamaliFRenal adverse effects of nonsteroidal anti-inflammatory drugsExpert Opin Drug Saf20098666968119832117
   PubMed Web of Science ®Google Scholar
• RothSHNSAID gastropathy. A new understandingArch Intern Med199615615162316288694659
   PubMedGoogle Scholar
• RothSHNonsteroidal antiinflammatory drug gastropathy: We started it, why don’t we stop it?J Rheumatol20053271189119115996051
   PubMed Web of Science ®Google Scholar
• SunCHERothSHMitchellCSEnglundDWUpper gastrointestinal disease in rheumatoid arthritisDig Dis1974195405410
   Web of Science ®Google Scholar
• HaroutiunianSDrennanDALipmanAGTopical NSAID therapy for musculoskeletal painPain Med201011453554920210866
   PubMed Web of Science ®Google Scholar
• ChanFKPrimer: Managing NSAID-induced ulcer complications – balancing gastrointestinal and cardiovascular risksNat Clin Pract Gastroenterol Hepatol200631056357317008926
   PubMedGoogle Scholar
• RaoPKnausEEEvolution of nonsteroidal anti-inflammatory drugs (NSAIDs): cyclooxygenase (COX) inhibition and beyondJ Pharm Pharm Sci200811281S110s19203472
   PubMed Web of Science ®Google Scholar
• RouzerCAMarnettLJCyclooxygenases: Structural and functional insightsJ Lipid Res200950SupplS29S3418952571
   PubMed Web of Science ®Google Scholar
• WeirMRSperlingRSReicinAGertzBJSelective COX-2 inhibition and cardiovascular effects: A review of the rofecoxib development programAm Heart J2003146459160414564311
   PubMed Web of Science ®Google Scholar
• McGettiganPHenryDCardiovascular risk and inhibition of cyclooxygenase: A systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2JAMA2006296131633164416968831
   PubMed Web of Science ®Google Scholar
• LazzaroniMPorroGBManagement of NSAID-induced gastrointestinal toxicity: Focus on proton pump inhibitorsDrugs2009691516919192936
   PubMed Web of Science ®Google Scholar
• LanasATorneroJZamoranoJLAssessment of gastrointestinal and cardiovascular risk in patients with osteoarthritis who require NSAIDs: The LOGICA studyAnn Rheum Dis20106981453145820498210
   PubMed Web of Science ®Google Scholar
• BardouMBarkunANPreventing the gastrointestinal adverse effects of nonsteroidal anti-inflammatory drugs: From risk factor identification to risk factor interventionJoint Bone Spine201077161220022539
   PubMed Web of Science ®Google Scholar
• No authors listed.H. pylori eradication in NSAID-associated ulcersDrug Ther Bull2005435374015903114
   PubMedGoogle Scholar
• ThomsenRWRiisAMunkEMNorgaardMChristensenSSorensenHT30-day mortality after peptic ulcer perforation among users of newer selective COX-2 inhibitors and traditional NSAIDs: A population-based studyAm J Gastroenterol2006101122704271017026569
   PubMed Web of Science ®Google Scholar
• DaviesNMLongstrethJJamaliFMisoprostol therapeutics revisitedPharmacotherapy2001211607311191738
   PubMed Web of Science ®Google Scholar
• GoldsteinJLCryerBAmerFHuntBCelecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: A randomized, double-blind, endoscopic trialClin Gastroenterol Hepatol20075101167117417916545
   PubMed Web of Science ®Google Scholar
• YangYXLewisJDEpsteinSMetzDCLong-term proton pump inhibitor therapy and risk of hip fractureJAMA2006296242947295317190895
   PubMed Web of Science ®Google Scholar
• OsterbergLBlaschkeTAdherence to medicationN Engl J Med2005353548749716079372
   PubMed Web of Science ®Google Scholar
• JohnsonREHornbrookMCHookerMCWoodsonGTShneidmanRAnalysis of the costs of NSAID-gastropathy. Experience in a US health maintenance organisationPharmacoeconomics1997121768810169389
   PubMed Web of Science ®Google Scholar
• WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal antiinflammatory drugsN Engl J Med1999340241888189910369853
   PubMed Web of Science ®Google Scholar
• SmalleyWEGriffinMRFoughtRLRayWAExcess costs from gastrointestinal disease associated with nonsteroidal anti-inflammatory drugsJ Gen Intern Med19961184614698872783
   PubMed Web of Science ®Google Scholar
• FendrickAMScheimanJMDecision analytic modeling and NSAID gastropathy: Could we be more sensitive?J Gen Intern Med200015643043110886479
   PubMed Web of Science ®Google Scholar
• CrossPLAshbyDHardingGAre topical or oral ibuprofen equally effective for the treatment of chronic knee pain presenting in primary care: A randomized controlled trial with patient preference studyBMC Musculoskelet Disord200565516274477
   PubMed Web of Science ®Google Scholar
• CastelnuovoECrossPMt-IsaSSpencerAUnderwoodMon behalf of the TOIB study teamCost-effectiveness of advising the use of topical or oral ibuprofen for knee pain; the TOIB studyRheumatology (Oxford)20084771077108118511476
   PubMed Web of Science ®Google Scholar
• RahmeEBarkunANAdamVBardouMTreatment costs to prevent or treat upper gastrointestinal adverse events associated with NSAIDsDrug Saf200427131019104215471508
   PubMed Web of Science ®Google Scholar
• Massó GonzálezELPastrignaniPTacconelliSGarcía RodríguezLAVariability among nonsteroidal antiinflammatory drugs in risk of upper gastrointestinal bleedingArthritis Rheum20106261592160120178131
   PubMed Web of Science ®Google Scholar
• DeeksJJSmithLABradleyMDEfficacy, tolerability, and upper gastrointestinal safety of celecoxib for treatment of osteoarthritis and rheumatoid arthritis: Systematic review of randomised controlled trialsBMJ2002325736561912242171
   PubMed Web of Science ®Google Scholar
• SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyJAMA2000284101247125510979111
   PubMed Web of Science ®Google Scholar
• WrightJMThe double-edged sword of COX-2 selective NSAIDsCMAJ2002167101131113712427705
   PubMed Web of Science ®Google Scholar
• MukherjeeDNissenSETopolEJRisk of cardiovascular events associated with selective COX-2 inhibitorsJAMA2001286895495911509060
   PubMed Web of Science ®Google Scholar
• FarkouhMEGreenbergBPAn evidence-based review of the cardiovascular risks of nonsteroidal anti-inflammatory drugsAm J Cardiol200910391227123719406264
   PubMed Web of Science ®Google Scholar
• SolomonDHGlynnRJRothmanKJSubgroup analyses to determine cardiovascular risk associated with nonsteroidal antiinflammatory drugs and coxibs in specific patient groupsArthritis Rheum20085981097110418668605
   PubMed Web of Science ®Google Scholar
• American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older PersonsPharmacological management of persistent pain in older personsJ Am Geriatr Soc20095781331134619573219
   PubMed Web of Science ®Google Scholar
• LanzaFLChanFKQuigleyEMPractice Parameters Committee of the American College of GastroenterologyGuidelines for prevention of NSAID-related ulcer complicationsAm J Gastroenterol2009104372873819240698
   PubMed Web of Science ®Google Scholar
• American Academy of Orthopaedic SurgeonsTreatment of Osteoarthritis of the Knee (Non-Arthoplasty) Full GuidelineRosemont, ILAmerican Academy of Orthopedic Surgeons2008
   Google Scholar
• MooreRADerrySMcQuayHJTopical agents in the treatment of rheumatic painRheum Dis Clin North Am200834241543218638684
   PubMed Web of Science ®Google Scholar
• SimonLSGriersonLMNaseerZBookmanAAZev ShainhouseJEfficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritisPain20091431323824519380203
   PubMed Web of Science ®Google Scholar
• TugwellPSWellsGAShainhouseJZEquivalence study of a topical diclofenac solution (Pennsaid) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: A randomized controlled trialJ Rheumatol200431102002201215468367
   PubMed Web of Science ®Google Scholar
• AltmanRBarkinRLTopical therapy for osteoarthritis: Clinical and pharmacologic perspectivesPostgrad Med2009121213914719332972
   PubMed Web of Science ®Google Scholar
• AltmanRDPractical considerations for the pharmacologic management of osteoarthritisAm J Manag Care2009158 SupplS236S24319817510
   PubMedGoogle Scholar
• RothSHSalicylates revisited. Are they still the hallmark of anti-inflammatory therapy?Drugs1988361163063491
   PubMed Web of Science ®Google Scholar
• CarnesDAnwerYUnderwoodMHardingGParsonsSTOIB Study TeamInfluences on older people’s decision making regarding choice of topical or oral NSAIDs for knee pain: Qualitative studyBMJ2008336763614214518056742
   PubMed Web of Science ®Google Scholar
• MakrisUEKohlerMJFraenkelLAdverse effects of topical non-steroidal anti-inflammatory drugs in older adults with osteoarthritis: A systematic literature reviewJ Rheumatol20103761236124320360183
   PubMed Web of Science ®Google Scholar
• BookmanAAWilliamsKSShainhouseJZEffect of a topical diclofenac solution for relieving symptoms of primary osteoarthritis of the knee: A randomized controlled trialCMAJ2004171433333815313991
   PubMed Web of Science ®Google Scholar
• RothSHShainhouseJZEfficacy and safety of a topical diclofenac solution (PENNSAID) in the treatment of primary osteoarthritis of the knee: A randomized, double-blind, vehicle-controlled clinical trialArch Intern Med2004164182017202315477437
   PubMedGoogle Scholar
• BaerPAThomasLMShainhouseZTreatment of osteoarthritis of the knee with a topical diclofenac solution: A randomised controlled, 6-week trial [ISRCTN53366886]BMC Musculoskelet Disord200564416086839
   PubMed Web of Science ®Google Scholar
• NiethardFUGoldMSSolomonGSEfficacy of topical diclofenac diethylamine gel in osteoarthritis of the kneeJ Rheumatol200532122384239216331769
   PubMed Web of Science ®Google Scholar
• BarthelHRHaselwoodDLongleyS3rdGoldMSAltmanRDRandomized controlled trial of diclofenac sodium gel in knee osteoarthritisSemin Arthritis Rheum200939320321219932833
   PubMed Web of Science ®Google Scholar
• BarafHSGoldMSClarkMBSafety and efficacy of topical diclofenac sodium 1% gel in knee osteoarthritis: A randomized controlled trialPhys Sportsmed2010382192820631460
   PubMed Web of Science ®Google Scholar
• Voltaren Gel (diclofenac sodium topical gel) 1% [prescribing information]Chadds Ford, PAEndo Pharmaceuticals Inc
   Google Scholar
• MurphyLSchwartzTAHelmickCGLifetime risk of symptomatic knee osteoarthritisArthritis Rheum20085991207121318759314
   PubMed Web of Science ®Google Scholar
• VivianeAVAlanBNEstimates of costs of hospital say for variceal and nonvariceal upper gastrointestinal bleeding in the United StatesValue Health20081111318237354
   PubMed Web of Science ®Google Scholar
• NiculescuLLiCHuangJMallenSPooled analysis of GI tolerability of 21 randomized controlled trials of celecoxib and nonselective NSAIDsCurr Med Res Opin200925372974019210159
   PubMed Web of Science ®Google Scholar
• MooreRADerrySMakinsonGTMcQuayHJTolerability and adverse events in clinical trials of celecoxib in osteoarthritis and rheumatoid arthritis: Systematic review and meta-analysis of information from company clinical trial reportsArthritis Res Ther200573R644R64515899051
   PubMed Web of Science ®Google Scholar